Closed Intravenous Catheter System on Catheter Success, Length of Stay and Complications
NCT ID: NCT05769452
Last Updated: 2023-03-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
214 participants
INTERVENTIONAL
2022-04-01
2022-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Peripheral Intravenous Catheter Bundle
NCT07249255
Comparing Peripherally Inserted Central Catheters to Long Peripheral Catheters in Pediatrics
NCT05346406
A Randomized Controlled Trial to Demonstrate the Safety and Efficacy of the OptiVein IV Catheter In a Pediatric Population
NCT02265380
Totally Implantable Catheters in Pediatric Hematology-oncology: a Study on Infectious Complications
NCT01304732
Catheter Resistance Monitoring to Predict Catheter-Associated Adverse Events in Children and Adolescents
NCT01737554
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The secondary aim of the research is; to evaluate the effect of two different catheter systems on the success of catheter placement and the development of complications in the first attempt in pediatric hematology and oncology patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
BD Nexiva™
The intervention group was given a closed IV catheter system called BD Nexiva™.
closed IV catheter system (BD Nexiva™)
There is a high-pressure extension set and a Q-syte split septum needle-free intervention device at the tip of the catheter. It creates a closed integrated system with this apparatus, reducing the risk of catheter-related bloodstream infection.
BD Insyte™ Autoguard™
The control group received an open IV catheter called BD Insyte™ Autoguard™.
open IV catheter (BD Insyte™ Autoguard™)
BD Instaflash™ needle technology improves initial entry success by confirming vascular access through the needle noch. It has flexible wings for secure cannula fixation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
closed IV catheter system (BD Nexiva™)
There is a high-pressure extension set and a Q-syte split septum needle-free intervention device at the tip of the catheter. It creates a closed integrated system with this apparatus, reducing the risk of catheter-related bloodstream infection.
open IV catheter (BD Insyte™ Autoguard™)
BD Instaflash™ needle technology improves initial entry success by confirming vascular access through the needle noch. It has flexible wings for secure cannula fixation.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Obtaining an informed consent form from the child patient and parent
* Child patient receiving intravenous therapy
Exclusion Criteria
1 Year
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gülçin Özalp Gerçeker
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gülçin Özalp Gerçeker
pHD, Assoc. Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nur Olgun, MD
Role: PRINCIPAL_INVESTIGATOR
Dokuz Eylul University
Hale Ören, MD
Role: PRINCIPAL_INVESTIGATOR
Dokuz Eylul University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gülçin Özalp Gerçeker
Izmir, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ozalp Gerceker G, Yildirim BG, Onal A, Oren H, Olgun HN, Bektas M. The effect of the closed intravenous catheter system on first insertion success, indwelling time, and complications in pediatric hematology and oncology patients: A randomized controlled study. Eur J Oncol Nurs. 2023 Dec;67:102430. doi: 10.1016/j.ejon.2023.102430. Epub 2023 Oct 7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DEU PHO nexiva
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.